Sculptor Capital’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-98,200
Closed -$374K 237
2019
Q3
$374K Sell
98,200
-25,300
-20% -$96.4K ﹤0.01% 178
2019
Q2
$821K Buy
+123,500
New +$821K ﹤0.01% 156